# Study Comparing Immune Response to, and Safety of, Fluviral and Fluzone Influenza Vaccines in Persons 50 y.o. and Over

> **NCT00232947** · PHASE3 · COMPLETED · sponsor: **ID Biomedical Corporation, Quebec** · enrollment: 900 (—)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Influenza virus vaccine (Fluviral)
- **BIOLOGICAL:** Influenza virus vaccine (Fluzone)

## Key facts

- **NCT ID:** NCT00232947
- **Lead sponsor:** ID Biomedical Corporation, Quebec
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** —
- **Final completion:** 2006-02
- **Target enrollment:** 900 (—)
- **Last updated:** 2007-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00232947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00232947, "Study Comparing Immune Response to, and Safety of, Fluviral and Fluzone Influenza Vaccines in Persons 50 y.o. and Over". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT00232947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*